Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Costs of genetic testing: Supporting Brazilian Public Policies for the incorporating of molecular diagnostic technologies

1 Sept 2015

Abstract excerpt

This study identifies and describes the operating costs associated with the molecular diagnosis of diseases, such as hereditary cancer. To approximate the costs associated with these tests, data informed by Standard Operating Procedures for various techniques was collected from hospital software and a survey of market prices. Costs were established for four scenarios of capacity utilization to represent the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA gene mutations in cancer
Share to Cystic Fibrosis Research Advances
Share to Genomics and Rare Diseases

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26500437
DOI: 10.1590/s1415-475738320140204

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Costs of genetic testing: Supporting Brazilian Public Policies for the incorporating of molecular diagnostic technologiesPMID 26500437Read ↗

The Cost of Hereditary Pediatric Cataract's Clinical and Genetic Diagnosis With Whole Exome Sequencing From a Middle-income Country Perspective: Can We See Any Gains?Semantic proximity Read ↗

Genetic Test Availability And Spending: Where Are We Now? Where Are We Going?Semantic proximity Read ↗

Development of a microcosting protocol to determine the economic cost of diagnostic genomic testing for rare diseases in AustraliaSemantic proximity Read ↗

Towards population-based genetic screenings for breast and ovarian cancer: A comprehensive review from economic evaluations to patient perspectives.Semantic proximity Read ↗

Economic evaluations of pharmacogenetic and genomic screening programs: update of the literature.Semantic proximity Read ↗

Predictive genetic tests and health system costs.Semantic proximity Read ↗

Cancer genetic counseling in public health care hospitals: the experience of three Brazilian services.Semantic proximity Read ↗

Micro-costing of genetic diagnostics in acute leukemia in Sweden: from standard-of-care to whole-genome sequencingSemantic proximity Read ↗

Cancer surveillance for patients with Li-Fraumeni Syndrome in Brazil: A cost-effectiveness analysisSemantic proximity Read ↗

Cost-Benefit Analysis of Genetic Testing as a Prenatal Diagnostic Tool for Thalassemia: A Single-Center Study From Central ThailandSemantic proximity Read ↗

Economic Impact of Low-Value Vitamin D Testing in BrazilSemantic proximity Read ↗

Cost and effectiveness of the California triple marker prenatal screening programSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.